News Home

What is Wall Street's Target Price for Viveve Medical Inc (VIVE) Stock Thursday?

Thursday, October 28, 2021 09:57 AM | InvestorsObserver Analysts
What is Wall Street's Target Price for Viveve Medical Inc (VIVE) Stock Thursday?

Analysts who follow Viveve Medical Inc (VIVE) on average expect it to climb 322.15% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. That average rating earns VIVE an Analyst Ranking of 75, which means it ranks higher than 75 of stocks, based on data compiled by InvestorsObserver.

Overall Score - 5
Wall Street analysts are rating VIVE a Strong Buy today. Find out what this means to you and get the rest of the rankings on VIVE!

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Viveve Medical Inc Stock Today?

Viveve Medical Inc (VIVE) stock is trading at $2.28 as of 9:54 AM on Thursday, Oct 28, an increase of $0.16, or 7.55% from the previous closing price of $2.12. The stock has traded between $2.17 and $2.40 so far today. Volume today is light. So far 491,365 shares have traded compared to average volume of 781,471 shares. Click Here to get the full Stock Report for Viveve Medical Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App